Literature DB >> 952573

Carbamazepine pharmacokinetics in young, adult and pregnant rats. Relation to pharmacological effects.

B M Assael, L Bossi, S Garattini, M Gerna, R Gomeni, P L Morselli.   

Abstract

Adult, male, female and pregnant rats were treated with single and repeated doses of carbamazepine (CBZ). The time course of the drug concentrations in plasma and tissues was followed. In all cases, data on plasma levels were subjected to pharmacokinetic analyses. Attempts were made to relate pharmacokinetic properties of carbamazepine to its effect on pentobarbital sleeping time and on protection against electroshock, after acute and repeated administration: --it was found that male rats eliminate carbamazepine faster than females: the total body clearance (TBC) was 16 ml/min/kg and 9.4 ml/min/kg, respectively. Two dose levels (25 and 50 mg/kg) had the same pharmacokinetic properties in young rats. Pregnant rats clear CBZ to a lesser extent than controls. --CBZ was found to accelerate its own elimination after repeated administration in both adult and young rats as revealed by the shortening of its half-life and an increase of 50% in clearance. Moreover, the protection against electroshock was significantly reduced after repeated administration, compared with a single-dose administration. Repeated administration of CBZ in rats shortens pentobarbital sleeping time and decreases the pentobarbital brain level significantly.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952573

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  4 in total

1.  Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery.

Authors:  D Battino; S Binelli; L Bossi; R Canger; D Croci; C Cusi; M De Giambattista; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

2.  Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.

Authors:  R P Remmel; M W Sinz; J C Cloyd
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

4.  Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.